Exploring the Feasibility of a Mindfulness-Music Therapy Intervention to Improve Anxiety and Stress in Adolescents and Young Adults with Cancer
Robert Knoerl(Dana-Farber Cancer Institute), Jennifer A. Ligibel(Dana-Farber Cancer Institute), Heather Woods(Dana-Farber Cancer Institute), Marlise R. Luskin(Dana-Farber Cancer Institute), Katherine A. Thornton(Memorial Sloan Kettering Cancer Center), Belinda T. Li(Boston University), Carolyn S. Phillips(Dana-Farber Cancer Institute), Elizabeth I. Buchbinder(Massachusetts General Hospital), A. Lindsay Frazier(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Donna L. Berry(Dana-Farber Cancer Institute), Ann S. LaCasce(Otsuka (Japan)), Emanuele Mazzola(Dana-Farber Cancer Institute)
Cited by 50
Related Papers
The International Consensus Classification of Mature Lymphoid Neoplasms: a report from the Clinical Advisory Committee
|Blood|2022|1.5k
A Cancer Cell Program Promotes T Cell Exclusion and Resistance to Checkpoint Blockade
|Cell|2018|1.4k
Navitoclax, a targeted high-affinity inhibitor of BCL-2, in lymphoid malignancies: a phase 1 dose-escalation study of safety, pharmacokinetics, pharmacodynamics, and antitumour activity
|The Lancet Oncology|2010|852
Individualised neoantigen therapy mRNA-4157 (V940) plus pembrolizumab versus pembrolizumab monotherapy in resected melanoma (KEYNOTE-942): a randomised, phase 2b study
|The Lancet|2024|729
Ipilimumab Therapy in Patients With Advanced Melanoma and Preexisting Autoimmune Disorders
|JAMA Oncology|2015|656